These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30742128)

  • 1. Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells.
    Zhu ZC; Liu JW; Yang C; Li MJ; Wu RJ; Xiong ZQ
    Cell Death Dis; 2019 Feb; 10(2):118. PubMed ID: 30742128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.
    Bellail AC; Tse MC; Song JH; Phuphanich S; Olson JJ; Sun SY; Hao C
    J Cell Mol Med; 2010 Jun; 14(6A):1303-17. PubMed ID: 19432816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
    Rosato RR; Almenara JA; Coe S; Grant S
    Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane expression of DR4, DR5 and caspase-8 levels, but not Mcl-1, determine sensitivity of human myeloma cells to Apo2L/TRAIL.
    Gómez-Benito M; Martinez-Lorenzo MJ; Anel A; Marzo I; Naval J
    Exp Cell Res; 2007 Jul; 313(11):2378-88. PubMed ID: 17462628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca2+/calmodulin signaling.
    Kaminskyy VO; Surova OV; Piskunova T; Zborovskaya IB; Tchevkina EM; Andera L; Zhivotovsky B
    Cell Death Dis; 2013 Mar; 4(3):e522. PubMed ID: 23470529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
    Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I
    Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde.
    Kim HB; Kim MJ; Kim DY; Lee JW; Bae JH; Kim DW; Kang CD; Kim SH
    Mol Cancer; 2011 Apr; 10():46. PubMed ID: 21513580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway.
    Yu W; Tiwary R; Li J; Park SK; Jia L; Xiong A; Simmons-Menchaca M; Sanders BG; Kline K
    Mol Carcinog; 2010 Nov; 49(11):964-73. PubMed ID: 20886583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
    Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
    Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimycin A sensitizes cells to TRAIL-induced apoptosis through upregulation of DR5 and downregulation of c-FLIP and Bcl-2.
    Lee SJ; Kim EA; Song KS; Kim MJ; Lee DH; Kwon TK; Lee TJ
    Int J Oncol; 2012 Oct; 41(4):1425-30. PubMed ID: 22842544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.
    Hassanzadeh A; Farshdousti Hagh M; Alivand MR; Akbari AAM; Shams Asenjan K; Saraei R; Solali S
    J Cell Physiol; 2018 Oct; 233(10):6470-6485. PubMed ID: 29741767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of active caspase 8 as a mechanism of acquired TRAIL resistance in mismatch repair-proficient colon carcinoma cell lines.
    Van Geelen CM; Pennarun B; Ek WB; Le PT; Spierings DC; De Vries EG; De Jong S
    Int J Oncol; 2010 Oct; 37(4):1031-41. PubMed ID: 20811726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level.
    Morizot A; Mérino D; Lalaoui N; Jacquemin G; Granci V; Iessi E; Lanneau D; Bouyer F; Solary E; Chauffert B; Saas P; Garrido C; Micheau O
    Cell Death Differ; 2011 Apr; 18(4):700-11. PubMed ID: 21072058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation.
    Fan S; Li Y; Yue P; Khuri FR; Sun SY
    Neoplasia; 2010 Apr; 12(4):346-56. PubMed ID: 20360945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vernodalol enhances TRAIL-induced apoptosis in diffuse large B-cell lymphoma cells.
    Wu W; Yang Y; Deng G; Ma L; Wei G; Zheng G; Han X; He D; Zhao Y; He J; Cai Z; Yu R
    Mol Carcinog; 2017 Oct; 56(10):2190-2199. PubMed ID: 28467689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of RIP and c-FLIP in preventing liver cancer cell apoptosis induced by TRAIL.
    Sun J; Luo H; Nie W; Xu X; Miao X; Huang F; Wu H; Jin X
    Int J Clin Exp Pathol; 2015; 8(6):6519-25. PubMed ID: 26261530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importin β1 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells.
    Kojima Y; Nakayama M; Nishina T; Nakano H; Koyanagi M; Takeda K; Okumura K; Yagita H
    J Biol Chem; 2011 Dec; 286(50):43383-93. PubMed ID: 22020938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression.
    Syed V; Mukherjee K; Godoy-Tundidor S; Ho SM
    J Cell Biochem; 2007 Oct; 102(2):442-52. PubMed ID: 17393432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells.
    Wang X; Chen W; Zeng W; Bai L; Tesfaigzi Y; Belinsky SA; Lin Y
    Mol Cancer Ther; 2008 May; 7(5):1156-63. PubMed ID: 18483303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.